PLASMA LEVELS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE 2 DIABETES AFTER LIPOPOLYSACCHARIDE INJECTION

被引：0
|
作者：
Berg, R. M. G. [1 ]
Andreasen, A. S. [1 ]
Pedersen, B. K. [1 ]
Moller, K. [1 ,2 ]
机构：
[1] Univ Copenhagen Hosp, Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen Hosp, Rigshosp, Intens Care Unit 4131, DK-2100 Copenhagen, Denmark
来源：
INTENSIVE CARE MEDICINE | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0947
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [21] American ginseng improves plasminogen activator inhibitor-1 concentrations in type 2 diabetes
    Vuksan, V
    Xu, Z
    Sievenpiper, JL
    Stavro, MP
    Beljan-Zdravkovic, U
    Di Buono, M
    Jenkins, AL
    DIABETES, 2001, 50 : A368 - A368
  • [22] Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels
    Mlekusch, W
    Schillinger, M
    Exner, M
    Sabeti, S
    Mannhalter, C
    Minar, E
    Wagner, O
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (04) : 717 - 723
  • [23] Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients
    Lindgren, A
    Lindoff, C
    Norrving, B
    Astedt, B
    Johansson, BB
    STROKE, 1996, 27 (06) : 1066 - 1071
  • [24] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY
    DAWSON, S
    HAMSTEN, A
    WIMAN, B
    HENNEY, A
    HUMPHRIES, S
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 183 - 190
  • [25] PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS THE PRIMARY INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PREGNANCY PLASMA
    JORGENSEN, M
    PHILIPS, M
    THORSEN, S
    SELMER, J
    ZEUTHEN, J
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) : 872 - 878
  • [26] Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease
    Abdul, S.
    Boender, J.
    Malfliet, J. J. M. C.
    Eikenboom, J.
    van Draat, K. Fijn
    Mauser-Bunschoten, E. P.
    Meijer, K.
    de Meris, J.
    Laros-van Gorkom, B. A. P.
    van der Bom, J. G.
    Leebeek, F. W. G.
    Rijken, D. C.
    de Willige, S. Uitte
    HAEMOPHILIA, 2017, 23 (03) : 437 - 443
  • [27] Plasminogen activator inhibitor-1 levels in patients with primary varicose vein
    Erguzel, N.
    Yetkin, E.
    Erdem, G.
    Erdil, N.
    Yetkin, G.
    Heper, G.
    Celik, T.
    Senen, K.
    INTERNATIONAL ANGIOLOGY, 2012, 31 (02) : 176 - 180
  • [28] Association between Plasma Levels of Plasminogen Activator Inhibitor-1 and Colorectal Neoplasms
    Kim, Eun Ran
    Yang, Mun Hee
    Lim, Yeun Jung
    Lee, Jin Hee
    Chang, Dong Kyung
    Kim, Young-Ho
    Son, Hee Jung
    Kim, Jae J.
    Rhee, Jong Chul
    Kim, Jin Yong
    GUT AND LIVER, 2013, 7 (05) : 519 - 523
  • [29] The plasma levels of plasminogen activator inhibitor-1 in subjects with white coat hypertension
    Çoban, E
    Ozdogan, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (06) : 541 - 544
  • [30] Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels
    Sakata, Toshiyuki
    Kario, Kazuomi
    ATHEROSCLEROSIS, 2011, 214 (02) : 490 - 491
12345